In the latest quarter, 6 analysts provided ratings for Inspire Medical Systems (NYSE:INSP), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
3
1
0
0
Last 30D
0
0
1
0
0
1M Ago
0
1
0
0
0
2M Ago
0
1
0
0
0
3M Ago
2
1
0
0
0
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $250.83, a high estimate of $285.00, and a low estimate of $185.00. Witnessing a positive shift, the current average has risen by 3.79% from the previous average price target of $241.67.
Exploring Analyst Ratings: An In-Depth Overview
The perception of Inspire Medical Systems by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Bob Hopkins
B of A Securities
Lowers
Neutral
$185.00
$225.00
Adam Maeder
Piper Sandler
Raises
Overweight
$255.00
$250.00
Shagun Singh
RBC Capital
Announces
Outperform
$285.00
-
Anthony Petrone
Mizuho
Maintains
Buy
$250.00
$250.00
Richard Newitter
Truist Securities
Maintains
Buy
$280.00
-
Kallum Titchmarsh
Morgan Stanley
Announces
Overweight
$250.00
-
Key Insights:
Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments ...Full story available on Benzinga.com
Benzinga
